Global Biopharma Cold Chain Logistics Package Market Growth (Status and Outlook) 2025-2031

According to this study, the global Biopharma Cold Chain Logistics Package market size will reach US$ 11140 million by 2031.

In the pharmaceutical industry, the quality of pharmaceutical products has a direct effect on patient safety and the efficacy of patient therapies. Temperature Controlled Package for Pharmaceutical is designed for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Biopharma Cold Chain Logistics Package Industry Forecast” looks at past sales and reviews total world Biopharma Cold Chain Logistics Package sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharma Cold Chain Logistics Package sales for 2025 through 2031. With Biopharma Cold Chain Logistics Package sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharma Cold Chain Logistics Package industry.

This Insight Report provides a comprehensive analysis of the global Biopharma Cold Chain Logistics Package landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharma Cold Chain Logistics Package portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharma Cold Chain Logistics Package market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharma Cold Chain Logistics Package and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharma Cold Chain Logistics Package.

This report presents a comprehensive overview, market shares, and growth opportunities of Biopharma Cold Chain Logistics Package market by product type, application, key players and key regions and countries.

Segmentation by Type:
Single Use
Reusable

Segmentation by Application:
Blood Products
Vaccines
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sonoco Products Company
Envirotainer
Pelican Biothermal
Cryopak
DS Smith Pharma
Cold Chain Technologies
Intelsius
CSafe
Softbox Systems
World Courier
Skycell
Va-Q-tec AG
Sofrigam SA Ltd.
American Aerogel Corporation
EcoCool GmbH
Aeris Group
Dokasch
HAZGO
Beijing Roloo Technology CO.,Ltd
Insulated Products Corporation
Inmark Packaging
Guangzhou CCTS
Exeltainer SL
Cool Pac
Cryo Store

Please note: The report will take approximately 2 business days to prepare and deliver. Show more